A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM

Clinical trial NCT04218734 · COMPLETED

Trial details

NCT number: NCT04218734
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2020-01-14
Primary completion: 2021-06-03
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.